 |
| MMWR Recommendations and Reports Vol. 64, No. RR-4 December 4, 2015 |
| In this report |
| Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident William A. Bower, MD; Katherine Hendricks, MD; Satish Pillai, MD, et al. MMWR Recomm Rep 2015;64(No. RR-4) An aerosolized release of Bacillus anthracis spores over densely populated areas could become a mass-casualty incident. This report addresses elements of hospital-based acute care, specifically antitoxins and intravenous antimicrobial use, and the diagnosis and management of common anthrax-specific complications during a mass-casualty incident. This report is intended for use by clinicians treating patients in the event of an anthrax mass-casualty incident and by federal, state, and local public health officials and health care administrators in the development of crisis protocols for such an incident. |
| MMWR Masthead |
| Department of Health and Human Services Centers for Disease Control and Prevention |
|
The CDC has reached 1 million email subscribers. Thank you for your support. Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates Questions or problems? Please contact support@xxxxxxxxxxxxxxx. |
   |
   |
| This email was sent to list-cdc@xxxxxxxxxxx using GovDelivery,on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30333 • 1-800-CDC-INFO (800-232-4636) |  |
